Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG.
Phase of Trial: Phase I/II
Latest Information Update: 15 Dec 2009
At a glance
- Drugs Epratuzumab Y-90 (Primary) ; DMP 525
- Indications B cell lymphoma; Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 10 Sep 2005 New trial record.